Serum-Leptin and Adiponectin Not Suitable Biomarkers for Multiple Sclerosis

Investigators examined whether serum leptin and adiponectin could be potential biomarkers of disease activity in multiple sclerosis.

Source link

Related posts

CBD Oil Arrives in Texas – Will it live up to expectations?


Balancing reality with hope in epilepsy therapy


Serological evidence of Japanese encephalitis virus circulation in Asian children from dengue-endemic countries.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy